Related Experiment Video
Updated: Mar 19, 2026

Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS
Published on: December 21, 2011
Vasoactive intestinal peptide dampens formyl-peptide-induced ROS production and inflammation by targeting a
P Chedid1,2,3, T Boussetta1,2,3, P M-C Dang1,2,3
1Inserm, U1149, CNRS-ERL8252, Centre de Recherche sur l'Inflammation (CRI), Paris, France.
Abstract:
Reactive oxygen species (ROS) produced by the phagocyte NADPH oxidase (NOX2) are required for microbial clearance; however, when produced in excess they exacerbate inflammatory response and injure surrounding tissues. NOX2 is a multicomponent enzyme composed of membrane-associated cytochrome b588 and cytosolic components p47phox, p67phox, p40phox, and rac1/2. We investigated whether vasoactive intestinal peptide (VIP), an endogenous immune-modulatory peptide, could affect ROS production by NOX2 in primary human phagocytes. VIP did not modulate basal ROS production by phagocytes, but it inhibited monocyte and not neutrophil ROS production in response to the bacterial peptide N-formyl-methionyl-leucyl-phenylalanine (fMLF). The action of VIP was essentially mediated by high-affinity G-protein coupled receptors VPAC1 as its specific agonist, [ALA11,22,28]VIP, mimicked VIP-inhibitory effect, whereas the specific VPAC1 antagonist, PG97-269, blunted VIP action. Further, we showed that VIP inhibited fMLF-induced phosphorylation of ERK1/2 (extracellular signal-regulated kinase 1/2), p38MAPK (p38 mitogen-activated protein kinase) pathways, and phosphorylation of p47phox on Ser345 residue. Also, VIP exerted an anti-inflammatory effect in a model of carrageenan-induced inflammation in rats. We thus found that VIP exerts anti-inflammatory effects by inhibiting the "MAPK-p47phox phosphorylation-NOX2 activation" axis. These data suggest that VIP acts as a natural anti-inflammatory agent of the mucosal system and its analogs could be novel anti-inflammatory molecules.
Insights
Vasoactive intestinal peptide (VIP) inhibits reactive oxygen species (ROS) production by phagocytes, specifically targeting the NOX2 enzyme. This peptide demonstrates anti-inflammatory effects by blocking key signaling pathways, suggesting its potential as a novel therapeutic agent.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Reactive oxygen species (ROS) are crucial for microbial clearance via phagocyte NADPH oxidase (NOX2) but can cause tissue damage when overproduced.
- NOX2 is a complex enzyme involving membrane-bound cytochrome b588 and cytosolic components like p47phox, p67phox, p40phox, and rac1/2.
Purpose of the Study:
- To investigate the effect of vasoactive intestinal peptide (VIP) on ROS production by NOX2 in human phagocytes.
- To elucidate the signaling pathways and receptors involved in VIP's modulation of NOX2 activity.
Main Methods:
- Primary human phagocytes were used to assess ROS production in response to bacterial peptide fMLF.
- VIP's effects were analyzed using specific agonists and antagonists for VPAC1 receptors.
- Western blotting was employed to examine the phosphorylation status of ERK1/2, p38MAPK, and p47phox.
- An in vivo rat model of carrageenan-induced inflammation was used to evaluate VIP's anti-inflammatory properties.
Main Results:
- VIP inhibited fMLF-induced ROS production in monocytes but not neutrophils.
- VIP's inhibitory action was mediated via the VPAC1 receptor.
- VIP suppressed the phosphorylation of ERK1/2, p38MAPK, and p47phox (Ser345).
- VIP demonstrated significant anti-inflammatory effects in a rat model of acute inflammation.
Conclusions:
- VIP acts as a natural anti-inflammatory agent, particularly within the mucosal system.
- VIP inhibits NOX2 activation through the "MAPK-p47phox phosphorylation-NOX2 activation" pathway.
- VIP and its analogs hold potential as novel therapeutic molecules for inflammatory conditions.
More Related Videos
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Nitric Oxide Signaling Pathway
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors